Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01368198 · ClinicalTrials.gov registry record · NA

Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion

A NA study of Dry Eye, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT01368198 is a NA study of Dry Eye that has completed, run by Alcon Research. The registered enrollment target is 50 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01368198, a NA study of Dry Eye, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this investigation will be to quantify the increase in tear film break-up time (TFBUT) associated with the instillation of a single eyedrop of an Ocular Emulsion in dry eye sufferers.

Conditions Studied

Dry Eye

Interventions

  • OTHER Systane Balance Lubricating Eye Drops
  • OTHER OPTIVE™

Study Locations (2)

Texas

  • Contact Alcon Call Center for Trial Locations - Fort Worth

England

  • OTG Research & Consultancy - London

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2011-03
Est. Completion 2011-06
Phase NA

Sponsor

Alcon Research

275 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01368198

The ClinicalTrials.gov registry entry for NCT01368198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (47% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 2 interventions - of which Systane Balance Lubricating Eye Drops is the first listed.

NCT01368198 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, England.

Frequently Asked Questions

What is clinical trial NCT01368198 about?

NCT01368198 is a clinical study titled "Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion". The primary objective of this investigation will be to quantify the increase in tear film break-up time (TFBUT) associated with the instillation of a single eyedrop of an Ocular Emulsion in dry eye sufferers.

What is the current status of trial NCT01368198?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-03. Estimated completion is 2011-06.

What conditions does trial NCT01368198 study?

This clinical trial studies the following conditions: Dry Eye.

What interventions are being tested in trial NCT01368198?

The interventions under investigation include: Systane Balance Lubricating Eye Drops (OTHER), OPTIVE™ (OTHER).

Who is sponsoring clinical trial NCT01368198?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01368198 being conducted?

This trial has 2 study locations across Texas, England. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dry Eye

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dry Eye

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.